AWM
RDY icon

Aprio Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Aprio Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,478
Closed -$138K – 428
2025
Q1 		$138K Sell
10,478
-8,329
-44% -$115K 0.02% 367
2024
Q4 		$297K Buy
18,807
+3,532
+23% +$53.1K 0.04% 217
2024
Q3 		$243K Buy
15,275
+1,900
+14% +$30.6K 0.04% 232
2024
Q2 		$204K Sell
13,375
-1,055
-7% -$15.1K 0.04% 239
2024
Q1 		$212K Buy
+14,430
New +$211K 0.04% 211

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aprio Wealth Management's RDY Position: Q2 2025 in Review

Aprio Wealth Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 10,478 shares — an estimated $138K sold.

Aprio Wealth Management first reported a position in RDY in Q1 2024 and held it in 5 quarters. The position peaked at $297K in Q4 2024. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

  • Aprio Wealth Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
  • Aprio Wealth Management sold 10,478 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $138K.
  • Aprio Wealth Management first reported a position in Dr. Reddy's Laboratories in Q1 2024 and held it in 5 quarters.
  • Aprio Wealth Management's Dr. Reddy's Laboratories position peaked at $297K in Q4 2024.
  • 243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on Aprio Wealth Management's 13F filing for Q2 2025, filed 14 Aug 2025.